Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.

about

ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients.ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.

P2860

Q38626147-BFF357BC-303F-42CA-8397-DF646731BE23 Q40084048-76ABE823-6B58-48B9-802B-DBEB3660E817

P2860

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.

Item

http://www.wikidata.org/entity/Q38962364

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Diagnosis of anaplastic lympho ...... cal smears versus cell blocks.

@en

type

Item

label

Diagnosis of anaplastic lympho ...... cal smears versus cell blocks.

@en

prefLabel

Diagnosis of anaplastic lympho ...... cal smears versus cell blocks.

@en

P1476

Diagnosis of anaplastic lympho ...... cal smears versus cell blocks.

@en

P2093

Giulio Rossi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bogina

http://www.w3.org/2001/XMLSchema#string

Giuseppina Liguori

http://www.w3.org/2001/XMLSchema#string

Maria Gabriella Malzone

http://www.w3.org/2001/XMLSchema#string

Matteo Brunelli

http://www.w3.org/2001/XMLSchema#string

Renato Franco

http://www.w3.org/2001/XMLSchema#string

P2860

Role of FNAC, fluid specimens, and cell blocks for cytological diagnosis of lung cancer in the present era

The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing

Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer

Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)

Management of malignant pleural effusions

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis.

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples

P304

303-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCY.21835

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28195686

http://www.w3.org/2001/XMLSchema#string

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.

about

P2860

P2860

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698